SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-072844
Filing Date
2018-12-13
Accepted
2018-12-13 17:02:00
Documents
3
Period of Report
2018-12-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-41545_18k.htm 8-K 36986
2 EX-99.1 a18-41545_1ex99d1.htm EX-99.1 25583
3 GRAPHIC g415451mmi001.jpg GRAPHIC 1459
  Complete submission text file 0001104659-18-072844.txt   66056
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS 441-295-5950
Axovant Sciences Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37418 | Film No.: 181233826
SIC: 2834 Pharmaceutical Preparations